(Q46863515)

25 December 2017

title

Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis (English)

1 reference

25 December 2017

1 reference

13

1 reference

25 December 2017

Owen J Sansom

14

1 reference

25 December 2017

author name string

Charles E Patek

1

1 reference

25 December 2017

Mark J Arends

2

1 reference

25 December 2017

William A H Wallace

3

1 reference

25 December 2017

Feijun Luo

4

1 reference

25 December 2017

Feijun Luo

5

1 reference

25 December 2017

Suzanne Hagan

6

1 reference

25 December 2017

David G Brownstein

7

1 reference

25 December 2017

Lorraine Rose

8

1 reference

25 December 2017

Paul S Devenney

9

1 reference

25 December 2017

Marion Walker

10

1 reference

25 December 2017

Sarah J Plowman

11

1 reference

25 December 2017

Rachel L Berry

12

1 reference

25 December 2017

David J Harrison

15

1 reference

25 December 2017

Martin L Hooper

16

1 reference

25 December 2017

language of work or name

English

0 references

publication date

17 November 2007

1 reference

25 December 2017

Experimental Cell Research

published in

1 reference

25 December 2017

volume

314

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

1105-1114

1 reference

25 December 2017

RAS oncogenes: the first 30 years.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Ras signaling from plasma membrane and endomembrane microdomains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

SmgGDS displays differential binding and exchange activity towards different Ras isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

K-ras regulates the steady-state expression of matrix metalloproteinase 2 in fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

K-ras mutations in non-small-cell lung carcinoma: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Knockdown of mutant K-ras expression by adenovirus-mediated siRNA inhibits the in vitro and in vivo growth of lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Complex effects of Ras proto-oncogenes in tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Wildtype Kras2 can inhibit lung carcinogenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Prevention of lung cancer progression by bexarotene in mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Detecting changes in the relative expression of KRAS2 splice variants using polymerase colonies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Developmentally-regulated expression of murine K-ras isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Alternative splicing of the K-ras gene in mouse tissues and cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

K-ras is an essential gene in the mouse with partial functional overlap with N-ras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Laser capture microdissection in pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Geranylgeranyltransferase I as a target for anti-cancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.11.004

10.1016/J.YEXCR.2007.11.004

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017